biomarkers of cardiotoxicity in multiple myeloma
Published 8 years ago • 225 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
3:00
current & emerging biomarkers in multiple myeloma
-
1:05
ultrastratification of multiple myeloma via biomarkers
-
5:10
what is multiple myeloma? - animated
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
2:17:49
introduction to biomarkers
-
2:17
mrd: a promising biomarker in multiple myeloma
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
5:37
biomarkers in ultra low-risk myeloma
-
1:58
genetic biomarker use in myeloma: updates from ash 2020
-
2:30
using biomarkers to identify molecular lesions and monitor response to treatment in multiple myeloma
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
2:35
inflammatory biomarkers as predictors of car-t efficacy in multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
7:07
multiple myeloma coverage on vjhemonc!
-
1:24
predictive biomarkers of response to venbd in r/r mm
-
5:06
advances in immunotherapy for multiple myeloma and future outlooks
-
2:28
advancements in prognostic biomarkers for personalized therapy in multiple myeloma